Are donor factors (age/sex), whole blood processing methods and/or red cell storage solutions associated with in-hospital mortality and/or other measures of transfusion efficacy or harm in patients who have received red cell transfusions?
Is there a risk-based framework for evaluating the blood donor selection process, to capture relevant risk factors for transfusion-transmitted diseases, while modifying policies that do not contribute to transfusion safety?
What are the biochemical and physiological responses to the acute blood and iron loss that occur during blood donation?
What is the effect of donation-induced iron deficiency on blood donor health?
How can blood centers prevent hypotensive reactions after blood donation?